Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • In-Cosmetics Global 2022 Exhibition & Conference

    In-Cosmetics Global 2022 Exhibition & Conference was held in Paris, France from 5th to 7th April 2022. It was focused on Innovation, be it innovation in Functional ingredients, Active ingredients, Green ingredients, Sensorial ingredients and it recognized the very best of the industry’s innovation by awarding them.

  • Newly identified cell type could be the key to restoring damaged salivary glands

    Scientists at Scripps Research and the National Institute of Dental and Craniofacial Research have discovered a special type of cell that resides in salivary glands and is likely crucial for oral health.

  • Basilea reports preclinical data on oncology drug candidates BAL0891

    Basilea Pharmaceutica Ltd a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, reported today that promising preclinical data on the anti-cancer activity of its three oncology drug candidates, BAL0891, derazantinib and lisavanbulin, have been presented at the Annual Meeting of the American Association for Cancer Research (AACR) that took place April 8-13, 2022, in New Orleans, USA.

  • Researchers Identify a New Treatment for Metabolic Syndrome

    Metabolic syndrome increases a person’s risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, published in Cell Metabolism, researchers at University Hospitals (UH), Harrington Discovery Institute at UH, and Case Western Reserve University have furthered their progress to develop a drug to treat metabolic syndrome by identifying a receptor that controls appetite and body weight.

  • SARS-CoV-2 : Neutralization of BA.1 and BA.2 by Therapeutic Monoclonal Antibodies

    The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients.

  • The DNA Technology Regulation Bill is under consideration

    Union Minister of State (Independent Charge) Science and Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said that , the Ministry of Home Affairs (MHA), has approved projects for strengthening DNA analysis, cyber-forensics and related facilities in 23 States/UTs under Nirbhaya Fund Scheme.

  • Biggest study of its kind implicates specific genes in schizophrenia

    The largest ever genetic study of schizophrenia has identified large numbers of specific genes that could play important roles in the psychiatric disorder.

    A group of hundreds of researchers across 45 countries analysed DNA from 76,755 people with schizophrenia and 243,649 without it to better understand the genes and biological processes underpinning the condition.

  • Researchers generate the first complete, gapless sequence of a human genome

    Scientists have published the first complete, gapless sequence of a human genome, two decades after the Human Genome Project produced the first draft human genome sequence. According to researchers, having a complete, gap-free sequence of the roughly 3 billion bases in our DNA is critical for understanding the full spectrum of human genomic variation and for understanding the genetic contributions to certain diseases.

  • Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH Inhibitor Programs at AACR 2022

    Rhizen Pharmaceuticals AG, a Switzerland-based privately held, clinical-stage oncology & inflammation-focussed biopharmaceutical company, announced the release of data on its differentiated next-generation clinical-stage PARP (Poly ADP-Ribose Polymerase) and DHODH (DiHydro Orotate DeHydrogenase) inhibitor programs at the American Association for Cancer Research (AACR) 2022 Annual Meeting.

  • Indian scientific patents doubled in last three years

    The three departments functioning under the Ministry of Science and Technology - Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Scientific and Industrial Research (DSIR) represent different areas of scientific research. These three departments have supported scientific research works, research publications, technology development; and has acquired significant scientific knowledge through innovations that contribute to the overall development of the country.

Subscribe to Pharma News